Literature DB >> 8503973

Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer.

P H Sugarbaker1.   

Abstract

Hematogenous metastases from primary colon or rectal cancer develop in a definite step-wise fashion. In most patients the primary tumor disseminates to local lymph nodes, to the liver, or to peritoneal surfaces. Lung metastases only develop after considerable progression of the secondary tumor deposits in liver or in lymph nodes. This is considered a metachronous or step-wise progression of the malignant process. Only in a minority of patients is there synchronous spread of the malignancy from the primary site to systemic sites. The dissemination of colorectal malignancy is in great contrast to the dissemination of other malignancies such as breast cancer or melanoma. Considerable autopsy and laboratory data support the metachronous pattern of dissemination. Metastatic inefficiency (overt destruction of a majority of tumor cells within blood vessels or lymphatic channels) explains the preponderance of metastatic deposits in the first capillary bed or first lymphatic network draining a primary colorectal malignancy. These observations constitute the scientific basis for resection of liver metastases from colorectal cancer and the large proportion of patients who can be cured by the surgical resection of one or a few liver metastases.

Entities:  

Mesh:

Year:  1993        PMID: 8503973     DOI: 10.1002/jso.2930530541

Source DB:  PubMed          Journal:  J Surg Oncol Suppl        ISSN: 1046-7416


  20 in total

1.  Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome.

Authors:  Andreas Andreou; Antoine Brouquet; Kishore G S Bharathy; Nancy D Perrier; Eddie K Abdalla; Steven A Curley; Matthias Glanemann; Daniel Seehofer; Peter Neuhaus; Jean-Nicolas Vauthey; Thomas A Aloia
Journal:  Surgery       Date:  2012-02-04       Impact factor: 3.982

Review 2.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

Authors:  Jeff H Tsai; Joana Liu Donaher; Danielle A Murphy; Sandra Chau; Jing Yang
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

4.  Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.

Authors:  Jürgen Weitz; Leslie H Blumgart; Yuman Fong; William R Jarnagin; Michael D'Angelica; Lawrence E Harrison; Ronald P DeMatteo
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma.

Authors:  Hirofumi Ichida; Hiroshi Imamura; Jiro Yoshimoto; Hiroyuki Sugo; Yoshiaki Kajiyama; Masahiko Tsurumaru; Kenji Suzuki; Yoichi Ishizaki; Seiji Kawasaki
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

6.  Asymptomatic isolated coccygeal metastasis in low rectal carcinoma.

Authors:  Duncan Stewart; P Kitsanta; J Hampton; A Shorthouse
Journal:  Tech Coloproctol       Date:  2009-07-16       Impact factor: 3.781

7.  A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.

Authors:  Nikol Snoeren; Emile E Voest; Andre M Bergman; Otilia Dalesio; Henk M Verheul; Rob A E M Tollenaar; Joost R M van der Sijp; Sander B Schouten; Inne H M Borel Rinkes; R van Hillegersberg
Journal:  BMC Cancer       Date:  2010-10-11       Impact factor: 4.430

Review 8.  Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion?

Authors:  A B Delaloye; B Delaloye
Journal:  Eur J Nucl Med       Date:  1995-06

Review 9.  Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.

Authors:  Zacharoula Panteleakou; Peter Lembessis; Antigone Sourla; Nikolaos Pissimissis; Aristides Polyzos; Charalambos Deliveliotis; Michael Koutsilieris
Journal:  Mol Med       Date:  2008-12-03       Impact factor: 6.354

Review 10.  The pre-metastatic niche: is metastasis random?

Authors:  Thomas R Cox; Alison Gartland; Janine T Erler
Journal:  Bonekey Rep       Date:  2012-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.